Clinical Trials Browser

Phase EARLY_PHASE1 × Irinotecan × 90 days × Clear all

NCT03554707 2026-05-08

SGT-53 in Children With Recurrent or Progressive CNS Malignancies

Phase EARLY_PHASE1 Withdrawn

Central Nervous System Neoplasms

NCT06011772 2026-03-11

EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer

Phase EARLY_PHASE1 Active not recruiting

Gastrointestinal

Colonic Neoplasms